Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.
D000293:Adolescent; D001241:Aspirin / Q000008:administration & dosage* / Q000627:therapeutic use*; D001772:Blood Cell Count; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D002449:Cell Aggregation; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006400:Hematocrit; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012075:Remission, Spontaneous; D012156:Reticulocytes; D013154:Spleen / Q000473:pathology; D013156:Splenectomy
D004176:Dipyridamole; D005337:Fibrin; D006493:Heparin; D001241:Aspirin; D006854:Hydrocortisone